relation: http://publicatio.bibl.u-szeged.hu/35431/ title: Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024 : EPICOVIDEHA-EPIFLUEHA Report creator: Salmanton-García Jon creator: Marchesi Francesco creator: Navrátil Milan creator: Piukovics Klára creator: Del Principe Maria Ilaria creator: Criscuolo Marianna creator: Bilgin Yavuz M creator: Fracchiolla Nicola S creator: Vena Antonio creator: Romano Alessandra creator: Falces-Romero Iker creator: Sgherza Nicola creator: Heras-Fernando Inmaculada creator: Biernat Monika M creator: Petzer Verena creator: Žák Pavel creator: Weinbergerová Barbora creator: Samarkos Michail creator: Erben Nurettin creator: van Praet Jens creator: López-García Alberto creator: Labrador Jorge creator: Lahmer Tobias creator: Drgoňa Ľuboš creator: Merelli Maria creator: Cuccaro Annarosa creator: Martín-Pérez Sonia creator: Dávila-Valls Julio creator: Farina Francesca creator: Cattaneo Chiara subject: 03.03. Egészségtudományok description: Community-acquired respiratory viral infections (CARV) significantly impact patients with hematological malignancies (HM), leading to high morbidity and mortality. However, large-scale, real-world data on CARV in these patients is limited. This study analyzed data from the EPICOVIDEHA-EPIFLUEHA registry, focusing on patients with HM diagnosed with CARV during the 2023-2024 autumn-winter season. The study assessed epidemiology, clinical characteristics, risk factors, and outcomes. The study examined 1312 patients with HM diagnosed with CARV during the 2023-2024 autumn-winter season. Of these, 59.5% required hospitalization, with 13.5% needing ICU admission. The overall mortality rate was 10.6%, varying by virus: parainfluenza (21.3%), influenza (8.8%), metapneumovirus (7.1%), RSV (5.9%), or SARS-CoV-2 (5.0%). Poor outcomes were significantly associated with smoking history, severe lymphopenia, secondary bacterial infections, and ICU admission. This study highlights the severe risk CARV poses to patients with HM, especially those undergoing active treatment. The high rates of hospitalization and mortality stress the need for better prevention, early diagnosis, and targeted therapies. Given the severe outcomes with certain viruses like parainfluenza, tailored strategies are crucial to improving patient outcomes in future CARV seasons. date: 2024 type: Folyóiratcikk type: PeerReviewed format: text identifier: http://publicatio.bibl.u-szeged.hu/35431/1/Salmanton-Garcia.pdf identifier: Salmanton-García Jon; Marchesi Francesco; Navrátil Milan; Piukovics Klára; Del Principe Maria Ilaria; Criscuolo Marianna; Bilgin Yavuz M; Fracchiolla Nicola S; Vena Antonio; Romano Alessandra; Falces-Romero Iker; Sgherza Nicola; Heras-Fernando Inmaculada; Biernat Monika M; Petzer Verena; Žák Pavel; Weinbergerová Barbora; Samarkos Michail; Erben Nurettin; van Praet Jens; López-García Alberto; Labrador Jorge; Lahmer Tobias; Drgoňa Ľuboš; Merelli Maria; Cuccaro Annarosa; Martín-Pérez Sonia; Dávila-Valls Julio; Farina Francesca; Cattaneo Chiara: Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024 : EPICOVIDEHA-EPIFLUEHA Report. AMERICAN JOURNAL OF HEMATOLOGY. ISSN 0361-8609 (2024) identifier: doi:10.1002/ajh.27565 relation: https://doi.org/10.1002/ajh.27565 relation: 35653108 language: eng relation: info:eu-repo/semantics/altIdentifier/doi/10.1002/ajh.27565 rights: info:eu-repo/semantics/openAccess